July 29, 2024 07:27 AM EDTUpdated 10:55 AM

Updated: GSK and Flagship to create up to 10 vaccines, medicines across respiratory and immunology

GSK and Flagship Pioneering will jointly pay up to $150 million to kick-start a respiratory and immunology tie-up.

The pair will create new vaccines and …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Up­dat­ed: GSK and Flag­ship to cre­ate up to 10 vac­cines, med­i­cines across res­pi­ra­to­ry and im­munol­o­gy